Business Description
Clariane SE
ISIN : FR0010386334
Share Class Description:
KRNMF: Ordinary SharesTotal Employee Number:
70,685Compare
Compare
Traded in other countries / regions
CLARI.France0OPS.UKKO2.GermanyKRNMF.USA IPO Date
2014-04-17Description
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.11 | |||||
Equity-to-Asset | 0.26 | |||||
Debt-to-Equity | 2.16 | |||||
Debt-to-EBITDA | 6.77 | |||||
Interest Coverage | 0.94 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 0.49 | |||||
Beneish M-Score | -3.03 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -13.5 | |||||
3-Year EBITDA Growth Rate | -11.8 | |||||
3-Year FCF Growth Rate | 22.6 | |||||
3-Year Book Growth Rate | -21.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 307.94 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 3.34 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 99.34 | |||||
9-Day RSI | 92.2 | |||||
14-Day RSI | 82.48 | |||||
3-1 Month Momentum % | 15.38 | |||||
6-1 Month Momentum % | 120.6 | |||||
12-1 Month Momentum % | 120.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.71 | |||||
Quick Ratio | 0.7 | |||||
Cash Ratio | 0.34 | |||||
Days Inventory | 27.82 | |||||
Days Sales Outstanding | 30.97 | |||||
Days Payable | 481.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -28.1 | |||||
Shareholder Yield % | 11.7 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 92.11 | |||||
Operating Margin % | 5.35 | |||||
Net Margin % | 0.03 | |||||
EBITDA Margin % | 21.72 | |||||
FCF Margin % | 15.39 | |||||
OCF Margin % | 20.22 | |||||
ROE % | 0.04 | |||||
ROA % | 0.01 | |||||
ROIC % | 1.99 | |||||
3-Year ROIIC % | -2.4 | |||||
ROC (Joel Greenblatt) % | 4.8 | |||||
ROCE % | 2.77 | |||||
Years of Profitability over Past 10-Year | 8 | |||||
Moat Score | 5 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 1025 | |||||
Forward PE Ratio | 21.76 | |||||
Shiller PE Ratio | 10.27 | |||||
Price-to-Owner-Earnings | 2.45 | |||||
PS Ratio | 0.28 | |||||
PB Ratio | 0.4 | |||||
Price-to-Free-Cash-Flow | 1.8 | |||||
Price-to-Operating-Cash-Flow | 1.37 | |||||
EV-to-EBIT | 27.75 | |||||
EV-to-Forward-EBIT | 24.37 | |||||
EV-to-EBITDA | 7.58 | |||||
EV-to-Forward-EBITDA | 9.73 | |||||
EV-to-Revenue | 1.65 | |||||
EV-to-Forward-Revenue | 2.31 | |||||
EV-to-FCF | 10.71 | |||||
Price-to-GF-Value | 3.5 | |||||
Price-to-Projected-FCF | 0.21 | |||||
Price-to-Median-PS-Value | 0.36 | |||||
Earnings Yield (Greenblatt) % | 3.6 | |||||
FCF Yield % | 55.7 | |||||
Forward Rate of Return (Yacktman) % | 39.92 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:KRNMF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Clariane SE Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 6,171.521 | ||
| EPS (TTM) ($) | 0.007 | ||
| Beta | -0.1621 | ||
| 3-Year Sharpe Ratio | 0.04 | ||
| 3-Year Sortino Ratio | 0.07 | ||
| Volatility % | 115.79 | ||
| 14-Day RSI | 82.48 | ||
| 14-Day ATR ($) | 0.001818 | ||
| 20-Day SMA ($) | 4.765 | ||
| 12-1 Month Momentum % | 120.6 | ||
| 52-Week Range ($) | 2.16 - 4.765 | ||
| Shares Outstanding (Mil) | 357.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Clariane SE Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Clariane SE Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Clariane SE Frequently Asked Questions
What is Clariane SE(KRNMF)'s stock price today?
The current price of KRNMF is $4.76. The 52 week high of KRNMF is $4.76 and 52 week low is $2.16.
When is next earnings date of Clariane SE(KRNMF)?
The next earnings date of Clariane SE(KRNMF) is .
Does Clariane SE(KRNMF) pay dividends? If so, how much?
Clariane SE(KRNMF) does not pay dividend.
Guru Commentaries on OTCPK:KRNMF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Clariane SE
No articles.